Home›People›Darien Parhad
DP

Darien Parhad

Executive officer at Paragon Biosciences Emalex Capital. Also an executive officer at Castle Creek Biosciences and CIRC Biosciences and a chief financial officer and treasurer at Evozyne.

ExecutiveRoles at 4 startups
Updated Nov 9, 2026·Latest SEC filing Jul 8, 2025·Suggest an edit

About Darien Parhad

Darien Parhad is an executive officer at Paragon Biosciences Emalex Capital.

Form D filings also name Darien Parhad as an executive officer at Castle Creek Biosciences and CIRC Biosciences and a chief financial officer and treasurer at Evozyne.

Darien Parhad first appears on SEC filings in 2018.

Experience

This experience comes from SEC filings. The years are when the filings name Darien Parhad in the role, so the role may have started earlier or lasted longer.

Paragon Biosciences Emalex Capital, Inc.
Executive officer
2018 – 2025 · Chicaco, IL
Castle Creek Biosciences, Inc.
Executive officer
2025 · Exton, PA
CIRC Biosciences, Inc.
Executive officer
2020 – 2024 · Chicago, IL
Evozyne, Inc.
Chief Financial Officer and Treasurer
2020 – 2023 · Chicago, IL

Key Colleagues at Startups

The people Darien Parhad works with at each company, as listed on that company's latest Form D.

PM
Patrick Morris
Executive Vice President and Secretary
JA
AG
EM
Eric Messner
Executive officer and director
RS
Ricky Sun
Director
JD
Castle Creek Biosciences, Inc. · Form D, Feb 25, 2025
DB
David Brill
Director
JA
MG
Matthew Gantz
Executive officer and director
PM
JS
Jude Sullivan
General Counsel and Assistant Secretary
AG
CIRC Biosciences, Inc. · Form D, Oct 7, 2024
TC
PM
Patrick Morris
President, Secretary and General Counsel, director
SC
Sai Chavala
Director
AG
JA
Evozyne, Inc. · Form D, Sep 29, 2023
AG
JA
Jeffrey Aronin
Chairman and Director
AT
Aris Theologis
Chief Business Officer
JS
Jude Sullivan
General Counsel and Secretary
AL
Aleina Lee
Corporate Controller
RR
Rama Ranganathan
Chief Scientific Officer and Director
PM
Patrick Morris
Executive officer and director
MG
Mike Gamson
President, Chief Executive Officer, and Director
MR
AR
Arjun Rallapalli
Chief Operating Officer

Sources

  1. SECParagon Biosciences Emalex Capital, Inc. Form D/A, filed Jul 8, 2025
  2. SECCastle Creek Biosciences, Inc. Form D, filed Feb 25, 2025
  3. SECCIRC Biosciences, Inc. Form D, filed Oct 7, 2024
  4. SECEvozyne, Inc. Form D, filed Sep 29, 2023